# A Clinical Study of the Interactions Between Azvudine Tablets (FNC) and Itraconazole Capsules (ICZ)

> **NCT07001501** · PHASE1 · COMPLETED · sponsor: **Henan Genuine Biotech Co., Ltd.** · enrollment: 15 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Azvudine tablets(FNC) and Itraconazole Capsules (ICZ)
- **DRUG:** Azvudine tablets(FNC) and Itraconazole Capsules (ICZ)
- **DRUG:** Azvudine tablets(FNC) and Itraconazole Capsules (ICZ)

## Key facts

- **NCT ID:** NCT07001501
- **Lead sponsor:** Henan Genuine Biotech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-21
- **Primary completion:** 2022-04-25
- **Final completion:** 2023-03-13
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2025-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07001501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07001501, "A Clinical Study of the Interactions Between Azvudine Tablets (FNC) and Itraconazole Capsules (ICZ)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07001501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*